Siegfried Holding AG (SFZN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Siegfried Holding AG (SFZN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9924
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding intermediates and controlled substances. Siegfried also offers development and production services for finished dosage forms including sterile filling. It serves principally companies operating in pharmaceutical industry. It has production facilities in the USA, Switzerland, Malta, China, Germany and France. The company offers its products in USA Europe and other countries. Siegfried is headquartered in Zofingen, Aargau Switzerland.

Siegfried Holding AG (SFZN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Siegfried Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Siegfried to Acquire Zofingen Manufacturing Facility from Arena Pharma 10
Siegfried Acquires API Businesses from BASF 11
Debt Offering 12
Siegfried to Raise Additional USD15.4 Million in Public Offering of 2.125% Bond Due 2021 12
Siegfried Raises USD149.6 Million in Public Offering of 2.125 Bond Due 2021 13
Siegfried Holding Raises USD61.33 Million in Bonds Offering 14
Acquisition 15
Siegfried Acquires Hameln Pharma for USD62 Million 15
Siegfried Acquires Alliance Medical Products For US$58 Million 16
Siegfried Holding AG – Key Competitors 17
Siegfried Holding AG – Key Employees 18
Siegfried Holding AG – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Financial Announcements 21
Aug 21, 2018: Siegfried reports higher sales and further improved margin for first half year 21
Mar 14, 2018: Siegfried with Sales and Margin Growth 23
Aug 23, 2017: Siegfried Reports Higher Profit and Increased Margin for First Six Months 24
Mar 14, 2017: Siegfried with Jump in Sales in 2016 25
Corporate Communications 26
Jun 04, 2018: Siegfried Group: Change in the Executive Committee 26
Mar 21, 2017: Siegfried Group: Management Changes 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Siegfried Holding AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Siegfried Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Siegfried Holding AG, Deals By Therapy Area, 2012 to YTD 2018 8
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Siegfried to Acquire Zofingen Manufacturing Facility from Arena Pharma 10
Siegfried Acquires API Businesses from BASF 11
Siegfried to Raise Additional USD15.4 Million in Public Offering of 2.125% Bond Due 2021 12
Siegfried Raises USD149.6 Million in Public Offering of 2.125 Bond Due 2021 13
Siegfried Holding Raises USD61.33 Million in Bonds Offering 14
Siegfried Acquires Hameln Pharma for USD62 Million 15
Siegfried Acquires Alliance Medical Products For US$58 Million 16
Siegfried Holding AG, Key Competitors 17
Siegfried Holding AG, Key Employees 18
Siegfried Holding AG, Subsidiaries 19

List of Figures
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Siegfried Holding AG (SFZN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 3I Group Plc:企業の戦略・SWOT・財務分析
    3I Group Plc - Strategy, SWOT and Corporate Finance Report Summary 3I Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Mothercare plc (MTC):企業の財務・戦略的SWOT分析
    Mothercare plc (MTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ActiveCare Inc (ACAR):企業の財務・戦略的SWOT分析
    Summary ActiveCare Inc (ActiveCare) is a medical equipment company that monitors health analytics. The company provides monitoring component to traditional disease management and wellness solutions. It offers solutions such as diabetes supplies, online web-based administrative tools, browser and iPh …
  • QDVC Q.S.C:企業の戦略的SWOT分析
    QDVC Q.S.C - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • China Vanke Co., Ltd.:企業の戦略・SWOT・財務情報
    China Vanke Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary China Vanke Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Acron (AKRN):企業の財務・戦略的SWOT分析
    Summary Acron produces and commercializes mineral fertilizers. The company offers ammonium nitrate, urea, ammonia, apatite concentrate, methanol, formalin, urea-formaldehyde resins, melamine-urea-formaldehyde resins and dipping resins, cerium, lanthanum, neodymium and didymium. Its products finds ap …
  • Western Digital Corp (WDC):企業の財務・戦略的SWOT分析
    Western Digital Corp (WDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Air France-KLM SA:戦略・SWOT・企業財務分析
    Air France-KLM SA - Strategy, SWOT and Corporate Finance Report Summary Air France-KLM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Benchmark Electronics Inc (BHE):企業の財務・戦略的SWOT分析
    Benchmark Electronics Inc (BHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • The Emirates Telecommunications Group:戦略・SWOT・企業財務分析
    The Emirates Telecommunications Group - Strategy, SWOT and Corporate Finance Report Summary The Emirates Telecommunications Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Valeura Energy Inc (VLE):石油・ガス:M&Aディール及び事業提携情報
    Summary Valeura Energy Inc (Valeura) is an upstream oil and gas company that explores for, develops and produces oil and natural gas. It operates mainly in the Thrace Basin in the northwest of Turkey pursuing conventional shallow natural gas, unconventional tight gas and a basin-centered gas accumul …
  • Straco Corporation Limited:企業の戦略・SWOT・財務情報
    Straco Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Straco Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Affimed GmbH (AFMD):企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, discovers and develops immunotherapies to treat hematologic cancers and solid tumors. The company is investigating AFM13, an innate cell engager, for the treatment of Peripheral T cell lymphoma, transformed …
  • LIC of India:企業の戦略・SWOT・財務分析
    LIC of India - Strategy, SWOT and Corporate Finance Report Summary LIC of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Shields Bag And Printing Company:企業の戦略・SWOT・財務分析
    Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report Summary Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Prestige Brands Holdings Inc (PBH):企業の財務・戦略的SWOT分析
    Prestige Brands Holdings Inc (PBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Resona Holdings, Inc.:企業の戦略・SWOT・財務分析
    Resona Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Resona Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • XuanZhu Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary XuanZhu Pharma Co Ltd (XuanZhu), a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd, is a developer and manufacturer of medicinal products. The company’s products comprise anti-infective drugs apapenem and benapenem; anti-acid drug anaprazole sodium, anti-diabetic drug imigliptin hydro …
  • Century Enka Limited:企業の戦略・SWOT・財務分析
    Century Enka Limited - Strategy, SWOT and Corporate Finance Report Summary Century Enka Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • S Group:企業の戦略的SWOT分析
    S Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆